BioStar Capital and Cue Growth led the $35m Series B financing round in Field Medical.

BioStar Capital, a venture capital firm, and Cue Growth, a late-stage venture capital and private equity firm, led the $35m Series B financing round in Field Medical, a clinical-stage medical device company focused on pulsed field ablation for complex cardiac arrhythmias, with participation from existing strategic investors. "This round reflects the momentum building behind Field Medical, not only from our clinical results, but also from the strength of our business fundamentals," Oskar Dadason, Field Medical CFO.